Copy Link Print Information

Enokizumab

(Synonyms: MEDI-528)
Customer Review

Based on 1 Customer Validation

Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.

For research use only. We do not sell to patients.

  • Purity: 99.23%
  • CAS No.: 909875-08-7
  • Molecular Weight:145.5 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Enokizumab
  • Experimental Validation Results for Enokizumab
  • Enokizumab Chemical Structure
    Enokizumab Chemical Structure
CAS No.: 909875-08-7
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Enokizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

All Interleukin Related Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Enokizumab (HY-P99193) neutralizes Recombinant Human IL-9 (HY-P7046) induced proliferation in the Mo7e cell line. The Neutralization Dose (ND50) for this effect is 0.043 μg/mL in the presence of 5 ng/mL Recombinant Human IL-9.

  • Enokizumab Chemical Structure
    1/16
  • Enokizumab
  • Enokizumab (HY-P99193) neutralizes Recombinant Human IL-9 (HY-P7046) induced proliferation in the Mo7e cell line. The Neutralization Dose (ND50) for this effect is 0.043 μg/mL in the presence of 5 ng/mL Recombinant Human IL-9.